Renaissance Technologies’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$867K Sell
32,700
-295,000
-90% -$7.82M ﹤0.01% 2581
2025
Q1
$7.91M Buy
+327,700
New +$7.91M 0.01% 1137
2024
Q4
Sell
-184,100
Closed -$11.7M 3939
2024
Q3
$11.7M Buy
184,100
+24,700
+15% +$1.56M 0.02% 964
2024
Q2
$8.45M Buy
+159,400
New +$8.45M 0.01% 1018
2023
Q3
Sell
-57,000
Closed -$924K 4144
2023
Q2
$924K Sell
57,000
-704,200
-93% -$11.4M ﹤0.01% 2513
2023
Q1
$12.7M Sell
761,200
-189,400
-20% -$3.15M 0.02% 964
2022
Q4
$8.94M Sell
950,600
-95,800
-9% -$901K 0.01% 1152
2022
Q3
$2.85M Buy
1,046,400
+180,200
+21% +$490K ﹤0.01% 1793
2022
Q2
$2.5M Sell
866,200
-101,149
-10% -$292K ﹤0.01% 2026
2022
Q1
$2.9M Buy
967,349
+724,476
+298% +$2.17M ﹤0.01% 1948
2021
Q4
$1.12M Buy
+242,873
New +$1.12M ﹤0.01% 2562
2021
Q1
Sell
-179,000
Closed -$1.01M 3738
2020
Q4
$1.01M Buy
179,000
+141,900
+382% +$799K ﹤0.01% 2490
2020
Q3
$216K Buy
+37,100
New +$216K ﹤0.01% 3082
2018
Q2
Sell
-832,500
Closed -$3.64M 3548
2018
Q1
$3.64M Sell
832,500
-70,800
-8% -$309K ﹤0.01% 2020
2017
Q4
$3.67M Buy
903,300
+500,700
+124% +$2.03M ﹤0.01% 1994
2017
Q3
$769K Buy
402,600
+103,600
+35% +$198K ﹤0.01% 2667
2017
Q2
$323K Buy
299,000
+33,200
+12% +$35.9K ﹤0.01% 2882
2017
Q1
$388K Buy
265,800
+102,600
+63% +$150K ﹤0.01% 2845
2016
Q4
$194K Buy
163,200
+141,900
+666% +$169K ﹤0.01% 3012
2016
Q3
$30K Buy
+21,300
New +$30K ﹤0.01% 3278